Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Huber

Showing results (101-110 of 752) with videos related to

Pageof 76
Sort By:
Wiener Klinische Wochenschrift|November 7, 2022
Risk stratification and risk-adapted management of acute pulmonary embolismNatascha Kohls, Stavros V Konstantinides, Irene Marthe Lang, et al.
Vascular Pharmacology|April 17, 2016
MicroRNAs as circulating biomarkers in acute coronary syndromes: A reviewFredrik Ahlin, John Arfvidsson, Kris G Vargas, et al.
Thrombosis and Haemostasis|January 26, 2012
Vasodilator-stimulated phosphoprotein-phosphorylation assay in patients on clopidogrel: does standardisation matter?Matthias K Freynhofer, Veronika Bruno, Martin Willheim, et al.
European Heart Journal|April 19, 2014
The organization, function, and outcomes of ST-elevation myocardial infarction networks worldwide: current state, unmet needs and future directionsKurt Huber, Bernard J Gersh, Patrick Goldstein, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 30, 2008
Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventionsThomas Cuisset, Harald Mudra, Oliver Muller, et al.
Critical Care Medicine|June 16, 2006
Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarctionAlexander Geppert, Angela Dorninger, Georg Delle-Karth, et al.
International Journal of Cardiology|January 8, 2017
Monocyte subsets in myocardial infarction: A reviewJohn Arfvidsson, Fredrik Ahlin, Kris G Vargas, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 4, 2025
Antiplatelet therapy in acute myocardial infarction complicated by cardiogenic shockAngela Dettling, Kurt Huber, Steen D Kristensen, et al.
Journal of Thrombosis and Thrombolysis|January 24, 2007
Antiplatelet drug induced isolated profound thrombocytopenia in interventional cardiology: a review based on individual case reportsThomas Höchtl, Linda Pachinger, Gerhard Unger, et al.
International Journal of Cardiology|October 5, 2018
Midregional pro-A-type natriuretic peptide as part of a dual biomarker strategy for the early rule out of non-ST segment elevation acute coronary syndrome - The WilCop studyMilos Tajsic, Rudolf Járai, Johannes Koch, et al.
Pageof 76

Showing results (101-110 of 752) with videos related to

Sort By:
Pageof 76
Wiener Klinische Wochenschrift|November 7, 2022
Risk stratification and risk-adapted management of acute pulmonary embolismNatascha Kohls, Stavros V Konstantinides, Irene Marthe Lang, et al.
Vascular Pharmacology|April 17, 2016
MicroRNAs as circulating biomarkers in acute coronary syndromes: A reviewFredrik Ahlin, John Arfvidsson, Kris G Vargas, et al.
Thrombosis and Haemostasis|January 26, 2012
Vasodilator-stimulated phosphoprotein-phosphorylation assay in patients on clopidogrel: does standardisation matter?Matthias K Freynhofer, Veronika Bruno, Martin Willheim, et al.
European Heart Journal|April 19, 2014
The organization, function, and outcomes of ST-elevation myocardial infarction networks worldwide: current state, unmet needs and future directionsKurt Huber, Bernard J Gersh, Patrick Goldstein, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 30, 2008
Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventionsThomas Cuisset, Harald Mudra, Oliver Muller, et al.
Critical Care Medicine|June 16, 2006
Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarctionAlexander Geppert, Angela Dorninger, Georg Delle-Karth, et al.
International Journal of Cardiology|January 8, 2017
Monocyte subsets in myocardial infarction: A reviewJohn Arfvidsson, Fredrik Ahlin, Kris G Vargas, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 4, 2025
Antiplatelet therapy in acute myocardial infarction complicated by cardiogenic shockAngela Dettling, Kurt Huber, Steen D Kristensen, et al.
Journal of Thrombosis and Thrombolysis|January 24, 2007
Antiplatelet drug induced isolated profound thrombocytopenia in interventional cardiology: a review based on individual case reportsThomas Höchtl, Linda Pachinger, Gerhard Unger, et al.
International Journal of Cardiology|October 5, 2018
Midregional pro-A-type natriuretic peptide as part of a dual biomarker strategy for the early rule out of non-ST segment elevation acute coronary syndrome - The WilCop studyMilos Tajsic, Rudolf Járai, Johannes Koch, et al.
Pageof 76